News

Androgen deprivation therapy for prostate cancer – an often forgotten risk factor for osteoporosis

Prostate cancer is the most common male solid organ malignancy. Almost half of the men with prostate cancer will be treated with androgen deprivation therapy (ADT) to suppress testosterone levels. While this improves disease-free survival and mortality, ADT is associated with a loss of BMD and an increased risk of fragility fracture. This complication will …

Androgen deprivation therapy for prostate cancer – an often forgotten risk factor for osteoporosis Read More »

Broadening the scope of osteoporosis intervention

Progressive bone mineral density (BMD) loss due to oestrogen deficiency in postmenopausal women is a key factor in ‘osteoporotic’ or ‘fragility’ fractures, with approximately 50 per cent of post-menopausal women experiencing at least one fracture after the age of 50.1 Due to the rapidly ageing global population, we are seeing an increasing trend in the …

Broadening the scope of osteoporosis intervention Read More »

blank

Placing the spotlight on “bone health”: Osteoporosis Australia rebrands itself

Osteoporosis Australia recently announced its official rebrand to ‘Healthy Bones Australia’, to reinforce the importance of prevention, in response to the concerning 173,000 broken bones sustained by  the Australian population last year. The organisation currently serves as APCO’s project management and Secretariat. The rebrand coincided with the publication of an article in MJA Insight, co-authored …

Placing the spotlight on “bone health”: Osteoporosis Australia rebrands itself Read More »

blank

International Osteoporosis Foundation launches a new Policy toolkit to help shape health policies

The International Osteoporosis Foundation (IOF) has launched a comprehensive toolkit – the ‘Capture the Fracture® Partnership – Guidance for Policy Shaping’, comprising a step-by-step policy guide to design and evaluate Post Fracture Care Coordination Programs in hospitals and health systems worldwide. Osteoporosis is a major public health concern, causing more than 8.9 million debilitating and …

International Osteoporosis Foundation launches a new Policy toolkit to help shape health policies Read More »

blank

New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific

Launch of first pan-Asia Pacific minimum clinical standards for the screening, diagnosis & management of osteoporosis   The Asia Pacific Consortium on Osteoporosis (APCO) has today (Thursday, January 28, 2021) launched the first pan-Asia Pacific clinical practice standards for the screening, diagnosis, and management of osteoporosis, targeting a broad range of high-risk groups. Published in …

New benchmark set to deliver optimal osteoporosis care throughout Asia Pacific Read More »

blank

A Tribute To A Legend In The Global Bone Arena

APCO mourns the passing of, and pays tribute to Professor Harry K Genant, a friend, respected colleague, and a true legend in the bone field. Dr Genant was Professor Emeritus, University of California San Francisco (UCSF), and Senior Consultant, and Chairman Emeritus of Bioclinica-Synarc, Inc. – a global contract research organization he co-founded in 1998, …

A Tribute To A Legend In The Global Bone Arena Read More »

blank

Hip fractures – Avoiding the black hole of missed management opportunities

Dr Nigel Gilchrist, Canterbury District Health Board, Christchurch, New Zealand and APCO Executive Committee Member Hip fractures in old adults are common, affecting up to 18 per cent of women and 6 per cent of men in their lifetime, and are associated with significant mortality and burden of disease. In the setting of prompt surgery and …

Hip fractures – Avoiding the black hole of missed management opportunities Read More »

blank

Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries

The number of individuals at risk for fragility fractures worldwide is predicted to increase two-fold from the 158 million it was in 2010, to 319 million in 2040. This grave projection is going to be felt most keenly in Asia; home to 4.5 billion people and to several rapidly aging societies. The financial costs associated …

Cost-effective fracture-probability based intervention thresholds for osteoporosis – one size does not fit all countries Read More »

blank

Modern day Alchemy? Bisphosphonates – the Elixir of Life?

Through millennia, alchemists and dreamers have striven to formulate the elixir of immortality and have failed – dramatically, ignominiously, and sometimes tragically. It is interesting to speculate whether bisphosphonates – agents that have been in clinical use for more than half a century, and in use for a quarter of that to inhibit bone resorption, …

Modern day Alchemy? Bisphosphonates – the Elixir of Life? Read More »

blank

Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam

A Developing economy with a per-capita GDP of around $2,600 (2018 figures), Việt Nam is the 15th most populous country in the world. It has a population of 97 million. The country’s population is greying fast. Although at present the proportion of the country’s population aged 60 years and older is 12%,  this is expected …

Charting a path for osteoporosis care in Developing countries – spotlight on Việt Nam Read More »

Scroll to Top